* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Virus interactions with endocytic pathways in macrophages and
Survey
Document related concepts
Lymphopoiesis wikipedia , lookup
Immune system wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Adaptive immune system wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Hepatitis B wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Henipavirus wikipedia , lookup
Transcript
*Manuscript Click here to download Manuscript: 010613_FINAL_REVTIM.docx Virus interactions with endocytic pathways in macrophages and dendritic cells Jason Mercer and Urs F. Greber ETH Zürich Institute of Biochemistry Schafmattstr. 18 CH-8093, Zürich, Switzerland [email protected] University of Zurich, Institute of Molecular Life Sciences Winterthurerstrasse 190 CH-8057 Zürich, Switzerland [email protected] Keywords: Endocytosis, macropinocytosis, receptors, trans-infection, macrophage, dendritic cells 1 Abstract Macrophages and dendritic cells are at the front line of defence against fungi, bacteria and viruses. Together with physical barriers such as mucus, and a range of antimicrobial compounds they constitute a major part of the intrinsic and innate immune systems. They have elaborate features, including pattern recognition receptors and specialized endocytic mechanisms, cytokines and chemokines, and the ability to call on reserves. As masters of manipulation and counter-attack viruses shunt intrinsic and innate recognition, enter immune cells, and spread from these cells throughout an organism. Here, we review recently described mechanisms by which viruses subvert endocytic and pathogensensing functions of macrophages and dendritic cells, while highlighting possible strategic advantages of infecting cells normally tuned into pathogen destruction. 2 The cell biology of virus infection The use of cell biological and molecular techniques has enabled virologists to understand the interplay between viruses and cells at the heart of the infection process. This is also shown in a recent surge of system-wide approaches, such as high-throughput RNAi screening, functional genomics or large-scale proteomics [for reviews, see 1, 2-4]. While these approaches are informing us about interactions between viruses and their host cells, for technical reasons, they have been performed in cell lines that may not be the major targets during natural infections. In the past few years there has been a push towards novel approaches and the use of primary cell lines or tissue culture systems that more accurately reflect the situation viruses encounter in an organism. This must involve the consideration of phagocytic cells, such as macrophages and dendritic cells (DCs). A recent example for a non-autonomous action of macrophages in viral entry has been the finding that apical entry of human adenovirus (HAdV) into polarized epithelial cells is facilitated by macrophage-derived chemokines, such as CXCL-8 [5]. These cytokines are released from macrophages upon contacting the virus. On highly polarized epithelial cells the cytokines trigger a redistribution of the viral entry receptors CAR and integrins from the basolateral to the apical membrane, thereby enabling infection from the luminal side of airways. The professionals: macrophages and DCs Why do macrophages and DCs take center stage for viral infections? These cells are specialized immune cells located throughout the body. By virtue of their fast chemotactic movements to sites of infection, they are often the first to encounter, identify, and engulf invading pathogens [6-10]. They decode the nature of the pathogen, and distinguish between soluble components of pathogens and the agents themselves, hence tuning inflammatory responses 3 [11]. Professional phagocytic cells generate reactive oxygen species highly toxic for pathogens, or they perforate membranes or digest invading pathogens by hydrolytic enzymes. The immune surveillance function of macrophages and DCs crucially depends on highly active endocytic processes [for reviews, see for example 7, 12]. This allows them to not only engulf and digest invading pathogens, but also present the products on their cell surface to T lymphocytes using major histocompatibility complex (MHC) molecules [reviewed in 11, 13]. T cells themselves produce soluble mediators, such as interferon gamma, which activate and enhance macrophage killing ability [14]. Macrophages and DCs fulfil two major functions in immunity, an innate and an adaptive function. Through efficient ingestion and destruction, pathogens are eliminated from circulation within the body, and second, the displayed antigens act in the initiation of an adaptive immune response. These events involve the production of cytokines, chemokines or reactive oxides, recruitment of other immune cells, and regulation of T cell activity and inflammation in response to the detected pathogen [11, 15, 16]. In the case of DCs these functions often overlap between subsets, with classical DCs being more efficient professional APCs and plasmacytoid DCs (pDCS), playing the role of the primary producer of type I interferon and pro-inflammatory cytokines in response to viral infection [17]. Endocytic mechanisms in macrophages and DCs Macrophages and classical DCs, referred to as DCs throughout, are professional phagocytes with exceptionally high endocytic activity. Besides phagocytosis, they carry out pinocytosis, such as clathrin- and non-clathrin-mediated endocytosis and macropinocytosis (Figure 1). These endocytic machineries are elaborate and deeply interconnected with signalling and the physiology of the particular cell type [for excellent reviews, see 18, 19-22]. The best understood 4 endocytic process is clathrin-mediated endocytosis (CME). It is strictly receptordependent and requires the coat protein clathrin, and the large GTPase dynamin for fission and release of clathrin-coated vesicles from the plasma membrane [23, 24]. Clathrin-independent mechanisms in turn give rise to distinct endocytic pathways generally independent of dynamin, as schematized in Figure 1 [for reviews, see 25, 26]. Some of these pathways have been implicated in repair processes, for example upon membrane insults [27]. Among the clathrin-independent pathways is macropinocytosis, a signal-induced transient actin-dependent process [18, 28]. In macrophages and DCs, however, macropinocytosis is wired as an on-going constitutive process [29, 30]. It is coupled to the migratory phenotype of these cells and essential for their immune function. Macropinocytosis is strictly dependent on actin and Na+/H+ exchangers. Na+/H+ exchangers rectify the cytosolic acidic pH proximal to activated tyrosine kinase receptors near the plasma membrane, and thereby relieve inhibition of guanine nucleotide exchange factors of Rho family GTPase [31]. Phagocytosis is mechanistically similar to macropinocytosis, albeit, unlike macropinocytosis, dependent on dynamin and a close apposition of a multivalent ligand with plasma membrane receptors [28, 32, 33]. It is key for maintaining tissue homeostasis and balancing innate and adaptive immune response to bacterial and fungal infections (Box 1). Given that phagocytosis is specified for particles typically larger than 0.5-1 µm [34, 35], viruses smaller than 0.5 µm are taken up by endocytosis rather than phagocytosis. Notable exceptions are reports for herpes simplex virus 1 (HSV-1) and Mimivirus [36, 37], or HAdV-C2 aggregated by soluble receptor fragments and targeted to the high affinity Fc receptor CD64 of human monocytes [38]. The vacuolar compartments formed during pinocytosis, macropinocytosis and phagocytosis are classical endosomes, macropinosomes and phagosomes, respectively. They follow similar maturation programs controlled by Rab GTPases and signalling phosphoinositide lipids [see 5 Figure 3, and 18, 33, 39]. Despite the similarities between these processes, we should keep in mind that pinocytosis, macropinocytosis and phagocytosis are tuned by specific machineries emerging from divergent receptor engagements and responses of subcellular networks [11, 40]. This leads to different forms of information processing and physiological reactions. Virus entry into macrophages and DCs Virus entry requires distinct cellular processes, typically attachment to receptors, signalling and movements of viruses on the cell surface, endocytic uptake and trafficking, and finally penetration and genome uncoating [for illustration, see Figure 2, and reviews by 41, 42, 43]. Despite their armaments, macrophages and DCs are not immune against viruses, and both DNA and RNA viruses can infect macrophages and/or DCs (Table 1). This is not surprising, since viruses have co-evolved with their hosts [44]. Mammals, for example, do not exclusively rely on macrophages and DCs for defence, but possess other potent pathogen killers, such as neutrophils and natural killer cells, which mount rapid responses against infected cells [34, 45]. Virus Receptors Virus attachment and receptor engagement on target cells have an important role in determining cell-type specificity and host range [reviewed in 46, 47]. A special feature of macrophages and DCs is the expression of pattern recognition receptors (PRRs), which function in pathogen detection and destruction [48]. PRRs bind to pathogen-associated molecular patterns (PAMPs) and thereby distinguish between ‘self’ and ‘non-self’. PRRs present in macrophages and DCs include RIG-I-like receptors (RLRs) and Toll-like receptors (TLRs) [49, 50]. The cytoplasmic RLRs (RIG-I and MDA5), and endosome-associated TLRs (TLR3, 7, 6 and 9) serve to decode viral features, such as capsid structures or nucleic acids, and initiate a fine-tuned production of antiviral pro-inflammatory cytokines and type I interferon [51]. The TLRs can act together with another class of PRRs, the scavenger receptors, which mediate non-opsonic phagocytosis of pathogens, and modulate the inflammatory response to TLR agonists [52]. Another set of PRRs comprises the C-type lectin receptors (CLRs) including mannose receptor, LSECtin (Liver and lymph node sinusoidal endothelial cell Ctype lectin), Siglec1, DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin), and its homologue DC-SIGNR. These receptors, present on both macrophages and DCs, are responsible for the recognition of viruses and other pathogens displaying the surface PAMP highmannose glycoproteins [53, 54]. Binding to these receptors leads to an innate immune response against these viruses [53, 55]. Interestingly, HIV, hepatitis C virus (HCV) or dengue virus can take advantage of DC-SIGN for attachment to cells (Table 1). Using a collection of phleboviruses, including Rift Valley fever and Uukuniemi viruses (UUKV), a recent study found that virus engagement of DC-SIGN by UUKV initiates a signalling cascade resulting in endocytosis and trafficking of the virus-receptor complex and infection [56]. Phleboviruses from the family of bunyaviridae are arboviruses transmitted during a blood meal of arthropods, such as insects. Dermal DCs are likely to be the first cells to encounter these viruses after delivery into the mammalian host. DC-SIGN mediated the delivery of UUKV to early endosomes. There the virus dissociated from the receptor and trafficked to late endosomes, where it penetrated to the cytosol, as shown by live cell fluorescence imaging experimentations. Whether DC-SIGN serves as an authentic receptor for phleboviruses other than UUKV, if DC-SIGN-mediated phlebovirus endocytosis requires a co-receptor, and what kind of endocytic mechanism is activated for DC-SIGN-mediated virus internalization will require further investigation. 7 Avoiding destruction in lysosomes The endo-lysosomal system of macrophages and DCs is designed for pathogen destruction and antigen presentation [11, 34]. For a pathogen, the lysosome of an antigen-presenting cell (APC) is a most hostile intracellular environment. It has extremely high proton concentrations (~pH 4.0), a combination of over 50 different proteases, lipases, DNAses, and other hydrolases, and reactive oxygen-, nitrogen-, and chloride-species. So why would a virus take such a risk? A likely answer is that endocytosis offers an evolutionary, immune-evasion advantage over direct fusion at the plasma membrane. Most importantly, this includes the presentation of a range of preexisting or induced entry portals along a dynamically changing endocytic pathway [57]. Maturation of vesicular compartments provides a cargo, such as a virus with a plethora of cues, such as decreasing pH, proteases or inorganic ions [reviewed in 58, 59]. Such cues can trigger the uncoating of virus genomes [43], or enable virus release from hostile compartments [60]. It is thus not surprising that even viruses that can fuse their envelope with the host membrane at neutral pH, such as HIV-1, HSV, human cytomegalovirus (HCMV) or respiratory syncytial virus (RSV) use endocytosis to gain entry into appropriate host cells [61-65]. A pathway of emerging interest for virus entry into immune cells is macropinocytosis [28, 39]. This has been shown for HAdV of the species B [66, 67], and vaccinia virus (VACV) mature- and extracellular- virions (MVs and EVs) in many different cell types [reviewed in 68]. A recent small compound inhibitor and localization study revealed that entry of both forms of VACV into monocytederived DCs (MDDCs) occurs by macropinocytosis, independent of the C-type lectin receptors [69]. Consistent with macropinocytic uptake, entry of virus particles was dependent on actin, Na+/H+ exchangers, phosphoinositide 3-kinase, intracellular calcium, and cholesterol. Just as important, entry was independent 8 of Fc- and complement receptors, clathrin, caveolin-1 and dynamin-2. Interestingly, after internalization virus did not co-localize with classical endocytic markers including EEA1 and Lamp2, or require low pH for fusion. Since this pathway is constitutive in non-activated macrophages and DCs, it would not require the use of a particular receptor for cell activation but rather be provided a ‘free ride’ into the cell. Although the ride is free for a virus, macropinocytic cargo can in fact be processed and presented on MHC I molecules [70], albeit not on MHC II [71]. Hence, viral escape from macropinosomes prior to lysosome fusion may be important for the avoidance of processing and reduced MHC I/II presentation. In line with this, delayed degradation of HIV-1 has been observed to occur upon macropinocytic uptake into macrophages [72]. In addition, as macropinosomes mature in parallel rather than merge into existing trafficking pathways, they may not expose the virus to the full repertoire of detection and destruction mechanisms present in classical endosomes and phagosomes. In fact, there is currently no evidence that endosome and phagosome associated TLRs are present in macropinosomes. In summary, a number of important human pathogens infecting macrophages and DCs (Table 1) utilize macropinocytosis for entry into other cells types, for example HIV, influenza A virus, Ebola, Kaposi’s sarcoma-associated virus (KSHV) and HAdV [66, 67, 73-79]. It will be of importance to determine if these and other viruses are using macropinocytosis to enter APCs, and if so, what consequences for infection and pathogen detection this may provide. Autophagy – anti-viral and pro-viral Macrophages and DCs respond to invading viruses by inducing autophagy, a process operating in close association with endosomal functions. The best studied autophagic process in immune cells is macroautophagy. This process 9 involves the formation of a cytosolic double-membrane which engulfs cytoplasmic material resulting in a new vesicle, termed an autophagosome [80]. Engulfed material can be degraded upon autophagosome fusion with late endosomes or lysosomes. It is becoming increasingly clear that macroautophagy and innate immune recognition modulate each other, to facilitate pathogen elimination in both professional and non-professional immune cells [81]. For example, the detection of extracellular pathogens by TLRs upregulates macroautophagy in mouse macrophage cell lines [82]. More specifically, pathogen elimination can occur by enhanced degradation of viral proteins or nucleic acids [83], by tinkering with the balance between cell death and survival of infected and bystander cells [84], through channelling cytosolic viral components to endosomal TLRs in plasmacytoid dendritic cells [85], or by feeding antigens to MHC class II compartments for activation of adaptive immunity [86]. On the other hand, viruses using the cytosol for transit or replication have adapted a multitude of strategies to subjugate macroautophagy. For example, to supply membrane for viral replication, to enhance cell survival or suppress cell death [reviewed in 87]. Further research is clearly needed to untangle the benefits and liabilities of macroautophagy for both viral pathogens and hosts, and to place these results into the context of viral endocytosis. Virus infiltration, hiding, and killing As discussed above, virus entry into macrophages and DCs may be a risky venture for a virus. Yet, viruses have come up with divergent ways to turn the tables on these sentinel cells [88]. For example, they modulate cytokine secretion or reduce antigen presentation, alter cellular trafficking, undergo latency or productive infection, and even interfere with cell death. Rather than discussing the underlying mechanisms, we highlight three general strategies for infiltration, hiding and killing APCs (Figure 4). 10 Infiltration In some cases, virus infection of DCs causes their activation and lowers their endocytic capacity thus shunting surveillance. Once activated by infection DCs migrate to the lymph nodes. Interestingly, several viruses that productively infect these cells take advantage of this process to facilitate virus spread. Both Ebola and HIV-1 infections result in partial maturation of DCs while promoting their migration [89, 90]. It is thought that HIV-1 uses DCs as a ‘Trojan horse’ for transport to lymph nodes where it infects CD4 T cells. Unlike DCs, CD4 T cells are major targets of HIV-1 for progeny production. T cell infection through DCs can occur by budding of virions from DCs and cell-free transmission. T cells can also be infected through DC-mediated cell-to-cell transmission via an immune-protective viral synapse, a process called trans-infection [91]. Trans-infection from immature DCs was suggested to require DC-SIGN [92] or other C-type lectins [93], although this was later found to be highly inefficient due to rapid degradation of virions after uptake [94, 95]. Conversely, trans-infection from mature DCs that relies on the CLR Siglec-1, rather than DC-SIGN, occurs efficiently [96]. In both cases these factors serve to capture but not promote virion fusion. In the simplest scenario, the captured HIV-1 is transferred directly to CD4 T-cells [97]. However, trans- infection has also been reported to involve macropinocytic internalization and subsequent regurgitation of virions by DCs [91, 98, 99]. Although up for debate [100], the internalization of virions may serve to effectively hide virions prior to trans-infection. Perhaps targeted exocytosis provides specific release of a large number of virions to the viral synapse only after formation of this immuneprotective environment has occurred. However there are still many questions regarding the mechanism of trans-infection, above all no in vivo evidence of this process has been documented. 11 Hiding Perhaps the best strategy for long-term viral survival is to simply hide from, rather than attack, host defences as evidenced by several chronic human viruses such as HIV-1, HCV or KSHV. These viruses can be latent, interfere with antigen processing and presentation, prevent APC maturation, or alter cytokine secretion [for a review, see 88]. Latency is most effective. It minimizes viral gene expression and under appropriate conditions, such as the encounter of a DC, can lead to viral gene expression from the latently integrated provirus in activated T cells [101]. For non-latent viruses the use of virus encoded proteins to prevent APC maturation and cytokine secretion is a common strategy [reviewed in 102]. The VP35 protein of Ebola virus, for example, has been demonstrated to be a multifunctional protein with immunosuppressive functions including inhibition of DC maturation and prevention of T cell activation [102, 103]. It effectively blocks the link between the innate and adaptive immune response during infection. Consistent with these reports, infection with some Ebola virus strains, such as Zaire, can be associated with a mortality rate approaching 90% [104], while Ebola virus lacking VP35 does not cause lethality [105]. These studies emphasize the importance of virus-encoded immune modulators to the outcome of infection. Killing Given their important immunological role macrophages and DCs would be expected to be prime targets for elimination by invading pathogens. However, only a few viruses, such as VACV or HSV-1 do so. Infection by these viruses triggers apoptosis of DCs [106, 107]. In these cases infection is abortive, but results in inhibition of DC maturation, antigen presentation, and subsequent T cell activation. The viral interference with DC function is crucial, since uninfected DCs can effectively activate T cells using antigens obtained by clearance of 12 infected apoptotic cells, for example in the case of HSV-1 or influenza A virus (IAV) [107, 108]. By killing of DCs, VACV and HSV-1 effectively reduce the number of APCs that can respond to the infection. That these cells no longer mature or secrete cytokines is likely to shunt the recruitment of additional immune cells to the site of infection. Additionally, as these cells are unable to activate T cells or migrate to secondary lymphoid tissue the activation of the adaptive immune response is likely slowed. Concluding remarks Multiple layers of cell defense control viral infections in an individual. Professional phagocytic DCs and macrophages are at the front line of this defense. Their phagocytic activities are key to activate natural killer cells, and limit the initial viremia prior to initiation of B and T cell mediated adaptive immunity. Further, DCs can cross-present viral antigens from infected B cells for T cell stimulation, and this may be key for virus-specific immune control. Neutralizing antibodies in turn control the plasma levels of viruses particularly upon lytic infections. To date in depth knowledge of virus entry and infection in macrophages and DCs is limited to only a subset of viral pathogens. It will be important to elucidate the major endocytic mechanisms used by viruses to enter macrophages and DCs, and how these pathways are linked to autophagy, an immediate antiviral activity within pathogen-sensing cells. It will be interesting to consider the different types of dendritic cells and macrophages within tissues exposed to pathogens, such as the lung. Focus will need to be placed on elucidating their virus interaction biology and innate responses in isolation or tissue context [109]. All of this can serve as a basis to determine how these pathways are linked to innate immunity and eventually immune evasion. Future work will also have to be directed at better understanding the in vivo implications of these findings. 13 Acknowledgments We would like to thank Dr. Maarit Suomalainen for critical reading and suggestions. Apologies to those whose work has not been referenced due to space limitations. JM is funded by an Ambizione grant from the Swiss National Science Foundation (SNF), and UFG by an SNF project grant (31003A_141222/1). References 1 Xue, Q. and Miller-Jensen, K. (2012) Systems biology of virus-host signaling network interactions. BMB Rep 45, 213-220 2 Damm, E.M. and Pelkmans, L. (2006) Systems biology of virus entry in mammalian cells. Cell Microbiol 8, 1219-1227 3 Friedel, C.C. and Haas, J. (2011) Virus-host interactomes and global models of virus-infected cells. Trends Microbiol 19, 501-508 4 Katze, M.G., et al. (2008) Innate immune modulation by RNA viruses: emerging insights from functional genomics. Nat Rev Immunol 8, 644-654 5 Lutschg, V., et al. (2011) Chemotactic anti-viral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. In Nat Commun, pp. 391 (310.1038/ncomms1391), Nature Publishing Group 6 Metschnikoff, E. (1891) Lecture on Phagocytosis and Immunity. Br Med J 1, 213-217 7 Norbury, C.C. (2006) Drinking a lot is good for dendritic cells. Immunology 117, 443-451 8 Murray, P.J. and Wynn, T.A. (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11, 723-737 9 Geissmann, F., et al. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661 10 Dale, D.C., et al. (2008) The phagocytes: neutrophils and monocytes. Blood 112, 935-945 11 Underhill, D.M. and Goodridge, H.S. (2012) Information processing during phagocytosis. Nat Rev Immunol 12, 492-502 12 Mellman, I. and Steinman, R.M. (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258 13 Brode, S. and Macary, P.A. (2004) Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology 112, 345-351 14 Nathan, C.F., et al. (1983) Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158, 670-689 15 MacMicking, J., et al. (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15, 323-350 14 16 Kotsias, F., et al. (2013) Reactive oxygen species production in the phagosome: impact on antigen presentation in dendritic cells. Antioxidants & redox signaling 18, 714-729 17 Macal, M., et al. (2012) Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection. Cell Host Microbe 11, 617-630 18 Kerr, M.C. and Teasdale, R.D. (2009) Defining macropinocytosis. Traffic 10, 364-371 19 Mayor, S. and Pagano, R.E. (2007) Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8, 603-612 20 McMahon, H.T. and Boucrot, E. (2011) Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 12, 517-533 21 Ewers, H. and Helenius, A. (2011) Lipid-mediated endocytosis. Cold Spring Harb Perspect Biol 3, a004721 22 Sigismund, S., et al. (2012) Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol Rev 92, 273-366 23 Schmid, S.L. and Frolov, V.A. (2011) Dynamin: functional design of a membrane fission catalyst. Annu Rev Cell Dev Biol 27, 79-105 24 Ferguson, S.M. and De Camilli, P. (2012) Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol 13, 75-88 25 Donaldson, J.G., et al. (2009) Clathrin-independent endocytosis: a unique platform for cell signaling and PM remodeling. Cellular signalling 21, 1-6 26 Sandvig, K., et al. (2011) Clathrin-independent endocytosis: mechanisms and function. Curr Opin Cell Biol 23, 413-420 27 Tam, C., et al. (2010) Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. J Cell Biol 189, 1027-1038 28 Mercer, J. and Helenius, A. (2009) Virus entry by macropinocytosis. Nat Cell Biol 11, 510-520 29 Garrett, W.S., et al. (2000) Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102, 325-334 30 Bohdanowicz, M., et al. (2013) Phosphatidic acid is required for the constitutive ruffling and macropinocytosis of phagocytes. Mol Biol Cell doi: 10.1091/mbc. 31 Koivusalo, M., et al. (2010) Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188, 547-563 32 Swanson, J.A. (2008) Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol 9, 639-649 33 Bohdanowicz, M. and Grinstein, S. (2013) Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis. Physiol Rev 93, 69-106 34 Haas, A. (2007) The phagosome: compartment with a license to kill. Traffic 8, 311-330 35 Flannagan, R.S., et al. (2011) The cell biology of phagocytosis. Annu Rev Pathol 7, 61-98 15 36 Clement, C., et al. (2006) A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol 174, 1009-1021 37 Ghigo, E., et al. (2008) Ameobal pathogen mimivirus infects macrophages through phagocytosis. PLoS Pathog 4, e1000087 38 Meier, O., et al. (2005) Early steps of clathrin-mediated endocytosis involved in phagosomal escape of Fcgamma receptor-targeted adenovirus. J Virol 79, 2604-2613 39 Mercer, J. and Helenius, A. (2012) Gulping rather than sipping: macropinocytosis as a way of virus entry. Curr Opin Microbiol 15, 490-499 40 Fairn, G.D. and Grinstein, S. (2012) How nascent phagosomes mature to become phagolysosomes. Trends Immunol 33, 397-405 41 Marsh, M. and Helenius, A. (2006) Virus entry: open sesame. Cell 124, 729740 42 Burckhardt, C.J. and Greber, U.F. (2009) Virus movements on the plasma membrane support infection and transmission between cells. PLoS Pathog 5, e1000621 43 Suomalainen, M. and Greber, U.F. (2013) Uncoating of non-enveloped viruses. Current opinion in virology 3, 27-33 44 Villarreal, L.P. and Witzany, G. (2010) Viruses are essential agents within the roots and stem of the tree of life. J Theor Biol 262, 698-710 45 Ferlazzo, G., et al. (2004) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172, 1455-1462 46 Grove, J. and Marsh, M. (2011) The cell biology of receptor-mediated virus entry. J Cell Biol 195, 1071-1082 47 Wolfrum, N. and Greber, U.F. (2013) Adenovirus signalling in entry. Cell Microbiol 15, 53-62 48 Takeuchi, O. and Akira, S. (2010) Pattern recognition receptors and inflammation. Cell 140, 805-820 49 Blasius, A.L. and Beutler, B. (2010) Intracellular toll-like receptors. Immunity 32, 305-315 50 Kawai, T. and Akira, S. (2006) Innate immune recognition of viral infection. Nat Immunol 7, 131-137 51 Bonjardim, C.A., et al. (2009) Interferons: signaling, antiviral and viral evasion. Immunol Lett 122, 1-11 52 Areschoug, T. and Gordon, S. (2009) Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell Microbiol 11, 1160-1169 53 Geijtenbeek, T.B., et al. (2004) Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 22, 33-54 54 van Vliet, S.J., et al. (2008) Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses. Immunology and cell biology 86, 580-587 55 Svajger, U., et al. (2010) C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cellular signalling 22, 1397-1405 16 56 Lozach, P.Y., et al. (2011) DC-SIGN as a receptor for phleboviruses. Cell Host & Microbe 10, 75-88 57 Doherty, G.J. and McMahon, H.T. (2009) Mechanisms of endocytosis. Annu Rev Biochem 78, 857-902 58 Huotari, J. and Helenius, A. (2011) Endosome maturation. Embo J 30, 34813500 59 Scott, C.C. and Gruenberg, J. (2011) Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH. BioEssays : news and reviews in molecular, cellular and developmental biology 33, 103-110 60 Barlan, A.U., et al. (2011) Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology 412, 306-314 61 Miyauchi, K., et al. (2009) HIV enters cells via endocytosis and dynamindependent fusion with endosomes. Cell 137, 433-444 62 Haspot, F., et al. (2012) Human Cytomegalovirus Entry into Dendritic Cells Occurs via a Macropinocytosis-Like Pathway in a pH-Independent and Cholesterol-Dependent Manner. PLoS One 7 (4):e34795 63 Vanarsdall, A.L., et al. (2012) PDGF receptor-alpha does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway. PLoS Pathog 8, e1002905 64 Nicola, A.V., et al. (2003) Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol 77, 5324-5332 65 Krzyzaniak, M.A., et al. (2013) Host Cell Entry of Respiratory Syncytial Virus Involves Macropinocytosis Followed by Proteolytic Activation of the F Protein. PLoS Pathog 9, doi:1003310.1001371 66 Amstutz, B., et al. (2008) Subversion of CtBP1 controlled macropinocytosis by human Adenovirus serotype 3. EMBO J. 27, 956-966 67 Kalin, S., et al. (2010) Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J Virol 84, 5336-5350 68 Schmidt, F.I., et al. (2012) Poxvirus host cell entry. Current opinion in virology 2, 20-27 69 Sandgren, K.J., et al. (2010) A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells. PLoS Pathog 6, e1000866 70 Peppelenbosch, M.P., et al. (2000) Macrophages present pinocytosed exogenous antigen via MHC class I whereas antigen ingested by receptormediated endocytosis is presented via MHC class II. J Immunol 165, 1984-1991 71 Watts, C. (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15, 821-850 72 Gobeil, L.A., et al. (2013) Macropinocytosis-like HIV-1 internalization in macrophages is CCR5 dependent and leads to efficient but delayed degradation in endosomal compartments. J Virol 87, 735-745 73 Marechal, V., et al. (2001) Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol 75, 11166-11177 17 74 de Vries, E., et al. (2011) Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 7, e1001329 75 Nanbo, A., et al. (2010) Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 6, e1001121 76 Saeed, M.F., et al. (2010) Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 6, e1001110 77 Valiya Veettil, M., et al. (2010) Interaction of c-Cbl with myosin IIA regulates Bleb associated macropinocytosis of Kaposi's sarcoma-associated herpesvirus. PLoS Pathog 6, e1001238 78 Hunt, C.L., et al. (2011) The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J Virol 85, 334-347 79 Carter, G.C., et al. (2011) HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 409, 234-250 80 Munz, C. (2011) Macroautophagy during Innate Immune Activation. Frontiers in microbiology 2, 72 81 Mizushima, N., et al. (2008) Autophagy fights disease through cellular selfdigestion. Nature 451, 1069-1075 82 Delgado, M.A., et al. (2008) Toll-like receptors control autophagy. Embo J 27, 1110-1121 83 Blanchet, F.P., et al. (2010) Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 32, 654-669 84 Campbell, G.R. and Spector, S.A. (2012) Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog 8, e1002689 85 Lee, H.K., et al. (2007) Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315, 1398-1401 86 Paludan, C., et al. (2005) Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307, 593-596 87 Lin, L.T., et al. (2010) Viral interactions with macroautophagy: a double-edged sword. Virology 402, 1-10 88 Rahman, S., et al. (2011) The tug-of-war between dendritic cells and human chronic viruses. Int Rev Immunol 30, 341-365 89 Bosio, C.M., et al. (2003) Ebola and Marburg viruses replicate in monocytederived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 188, 1630-1638 90 Harman, A.N., et al. (2006) HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol 177, 7103-7113 91 McDonald, D., et al. (2003) Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300, 1295-1297 92 Geijtenbeek, T.B., et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1binding protein that enhances trans-infection of T cells. Cell 100, 587-597 18 93 Gummuluru, S., et al. (2003) Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J Virol 77, 12865-12874 94 Sanders, R.W., et al. (2002) Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J Virol 76, 7812-7821 95 Turville, S.G., et al. (2004) Immunodeficiency virus uptake, turnover, and 2phase transfer in human dendritic cells. Blood 103, 2170-2179 96 Izquierdo-Useros, N., et al. (2012) Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol 10, e1001448 97 Cavrois, M., et al. (2007) In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog 3, e4 98 Wang, J.H., et al. (2008) Macropinocytosis and cytoskeleton contribute to dendritic cell-mediated HIV-1 transmission to CD4+ T cells. Virology 381, 143154 99 Kwon, D.S., et al. (2002) DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16, 135-144 100 Cavrois, M., et al. (2008) The achilles heel of the trojan horse model of HIV-1 trans-infection. PLoS Pathog 4, e1000051 101 van der Sluis, R.M., et al. (2013) Dendritic Cell-induced Activation of Latent HIV-1 Provirus in Actively Proliferating Primary T Lymphocytes. PLoS Pathog 9, e1003259 102 Cunningham, A.L., et al. (2010) Manipulation of dendritic cell function by viruses. Current opinion in microbiology 13, 524-529 103 Leung, D.W., et al. (2010) Ebolavirus VP35 is a multifunctional virulence factor. Virulence 1, 526-531 104 Mahanty, S. and Bray, M. (2004) Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4, 487-498 105 Hartman, A.L., et al. (2008) Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. J Virol 82, 2699-2704 106 Engelmayer, J., et al. (1999) Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol 163, 67626768 107 Bosnjak, L., et al. (2005) Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol 174, 2220-2227 108 Smed-Sorensen, A., et al. (2012) Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog 8, e1002572 109 Fejer, G., et al. (2013) Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions. Proc Natl Acad Sci U S A 19 Figure legends Figure 1. Endocytic mechanisms. The endocytic activities executed by cells are classified into pinocytic, macropinocytic, or phagocytic mechanisms. The various pinocytic mechanisms are classified based on their cellular requirements, that is, dynamin or actin. For each mechanism the major players are listed (in bold). While a major fraction of studies have been conducted to understand clathrin-mediated, macropinocytic and phagocytic mechanisms in non-professional phagocytes, professional phagocytes may use the full range of endocytic mechanisms. Although not fully understood, it is likely that viruses have learned to subjugate the majority of these pathways for infection of both professional and non-professional phagocytes. Figure 2. A classical virus entry program. The entry of a virus into a cell is a complex multi-step program involving a multitude of cellular and viral factors. After initial binding viruses often transit the cell surface in search of their preferred receptor. For direct penetration, receptor binding may result in a series of changes in the virus fusion machinery that facilitate its activation to promote fusion with the plasma membrane and delivery of the virus capsid into the host cytosol. In the case of endocytosis, receptor engagement causes the host cell to respond through the induction of a signaling cascade that initiates endocytic uptake of the virus itself. The passage through endosomes then provides cues for virus penetration. In both scenarios, free virus capsids are transported to the site of viral genome uncoating, for example in a microtubule-dependent fashion. The final stage of virus entry is the complete uncoating of the viral genome, which can occur either in the cytoplasm or the nucleus. 20 Figure 3. Endosomal trafficking and antigen presentation. Presented are the organelles associated with the main endocytic mechanisms at work in macrophages and DCs. The classic endocytic pathway is responsible for trafficking of cargoes derived from clathrin- and non-clathrin- mediated endocytosis. The organelles associated with this pathway are early endosomes (EEs), late endosomes (LEs), and lysosomes (LYs). The maturation program of these organelles, consisting of changes in Rab (Ras related in brain) proteins and lipid-composition profiles, as well as a gradual lowering of pH, and their centripetal trafficking are relatively well defined. Both macropinosomes and phagosomes mature in a fashion parallel to that of classical endosomes, going through distinct early macropinosomes (EM), early phagosomes (EP) and late macropinosomes (LM), late phagosomes (LP) stages. All of the pathways converge at the level of lysosome fusion where upon incoming pathogens are destroyed and ultimately presented as antigenic non-self peptides at the cell surface in the context of MHC class I and II. Whether phagolysosomal and macrolysosomal organelles are identical or represent distinct entities remains unknown. Figure 4. Virus exploitation of DC infection. Often virus infection of immature DCs stimulates their activation. If everything were to go to plan this would result in a maturation program marked by the expression of cell surface molecules which signal that a possible invader has been detected. This includes the cell surface expression of maturation markers (CD80/CD40), induction of DC migration to the lymph through up-regulation of CCR7, the release of cytokines to attract and stimulate the activity of additional immune cells, and the processing and presentation of antigen which in turn drives T cell activation. However, viruses have devised multiple strategies to prevent the full assault from DCs and slow the activation of the adaptive immune response. These include infiltrating, hiding, and in some cases killing of infected 21 DCs. Infiltration is used by some viruses to rapidly spread infection to additional target cells, such as T cells. In this scenario, maturation, antigen presentation, and cytokine secretion is shunted, while migration of the infected DCs is unabated. Depending on the virus, infection can be productive, or virions can be captured on the cell surface and passed along. Another strategy used by viruses to subvert DCs is hiding. Given the number of successful chronic human infections that practice hiding, it is probably the most successful mechanism. In most cases the viral infection results in latency or only low-level productive infection. As seen during infiltration DC maturation, antigen presentation, and cytokine secretion are blocked by specific viral effectors. Although only practiced by a few viruses, the most straight-forward strategy used by viruses to deal with DCs is killing. In these cases, infection tends to be abortive and all facets of DC activation and maturation are attenuated. Box1. Phagocytosis Phagocytosis is one of the major endocytic mechanism employed by macrophages and dendritic cells for the uptake of large particulate matter. It is a highly conserved, specialized endocytic mechanism involved in several essential functions including the anti-inflammatory clearance of apoptotic debris. While not typically involved in virus uptake, phagocytosis is essential for ingestion, destruction, and antigenic presentation of foreign pathogens, such as bacteria and fungi, underscoring its importance in innate immunity (for details, see main text). Particular features of phagocytosis include: Exclusive to professional phagocytes (i.e. neutrophils, macrophages and dendritic cells). Reserved for particles larger than 0.5-1 µm. The particle being internalized drives phagosome size and shape. Activation and uptake are site-specific. Typically requires opsonins (i.e. immunoglobulin G and complement). Can mediate pro- or anti-inflammatory responses depending on antigen. 22 Figure 1 Pinocytosis Macropinocytosis Phagocytosis Ac>n RhoA Caveolae dependent IL-‐2 pathway CLIC/ GEEC Arf6 dependent Flo>llin dependent Clathrin mediated Caveolin-‐1 Cavins RhoA Rac1 GRAF1 CDC42 Arf6 PIP(5)K Flo>llin Fyn Clathrin AP-‐2 Na+H+ Ac>n Ac>n Ab/FcR Dynamin-‐II Clathrin Ab-‐coated par>cle Figure 2 Binding & Receptor Engagement Direct Penetra;on Signalling & Endocytosis Trafficking Microtubule Transport Penetra;on Genome Uncoa;ng Nucleus Cytoplasm Figure 3 Macropinocytosis Pinocytosis CME Phagocytosis Non-‐CME EE EM LM LE EP Rab5/EEA1 Rab7/Lamp1 LP Lamp1 LY ? Dynamin-‐II 6.5 pH Clathrin Ac=n Ab-‐coated par=cle Ab/FcR MHC I MHC II 4.0 An=genic pep=des Figure 4 Immature Dendri-c Cell Ac-vated/Mature Dendri-c Cell An-gen presenta-on/ T cell ac-va-on Matura-on (CD80/CD40) Immature CD4+ or CD8+ T cell Cytokine secre-on Migra-on (CCR7) Immature T cell Infiltra-on Produc-ve Infec-on Hiding Killing Latent/Produc-ve Infec-on (low) Abor-ve Infec-on Matura-on Matura-on Matura-on An-gen presenta-on An-gen presenta-on An-gen presenta-on Cytokine secre-on Cytokine secre-on Cytokine secre-on Migra-on Migra-on Migra-on Viral genome Viral effector proteins MHC I MHC II An-genic pep-des Box1 Figure Click here to download high resolution image Table I Table 1. Viruses that infect DCs and macrophages a Virus Genome/envelope (+/-) Infections of DCs HIV-1 ssRNA+ (+) SARS ssRNA+ (+) HCV ssRNA+ (+) HRV6 ssRNA+ (-) Ebola ssRNA- (+) Measles ssRNA- (+) Dengue ssRNA+ (+) RSV ssRNA- (+) Influenza A Segmented ssRNA- (+) Uukuniemi Segmented ssRNA- (+) Rift Valley fever Segmented ssRNA- (+) LCMV Segmented ssRNA- (+) HBV ss/dsDNA (+) Adenovirus dsDNA (-) HSV-1 dsDNA (+) HHV8/KSHV dsDNA (+) HCMV dsDNA (+) VZV dsDNA (+) EBV dsDNA (+) Vaccinia dsDNA (+) Infections of macrophages HIV-1 ssRNA+ (+) Ebola ssRNA- (+) RSV ssRNA- (+) Influenza A Segmented ssRNA- (+) a b Productive c Receptor(s) d +/+ + + + + +/+ + + + + + - DC-SIGN DC-SIGN CD81/CLDN1 N.D. NPC1 SLAM DC-SIGN N.D. DC-SIGN DC-SIGN DC-SIGN α-dystroglycan NTCP DC-SIGN/Lf DC-SIGN DC-SIGN DC-SIGN IDE N.D. N.D. +/+/- DC-SIGN/ICAM3 NPC1 N.D. DC-SIGN Virus abbreviations: HIV-1, human immunodeficiency virus-1; SARS, sudden acute respiratory syndrome; HCV, hepatitis C virus; HRV6, human rhino virus 6; RSV, respiratory syncytial virus; LCMV, lymphocytic choriomeningitis virus; HBV, hepatitis B virus; HSV-1, herpes simplex virus-1; HHV8/KSHV, human herpes virus 8/Kaposi’s sarcoma herpes virus; HCMV, human cytomegalovirus; VZV, varicella-zoster virus; EBV, Epstein-Barr virus. b Genome structure abbreviations: ss, single-stranded; ds, double stranded. For RNA genomes +/indicates the sense of the RNA. If the virus is enveloped (+) or non-enveloped (-) is indicated c Whether virus infection is productive (+), non-productive (-), or varies depending on the literature (+/-) is indicated. d Receptor abbreviations: DC-SIGN, dendritic cell-specific intercellular adhesion molecule-3grabbing non-integrin); CLDN1, claudin-1; NPC1, Niemann–Pick C1; SLAM, signalling lymphocyte-activation molecule; NTCP, sodium taurocholate cotransporting polypeptide; Lf, lactoferrin; IDE, insulin-degrading enzyme; ICAM3, intercellular adhesion molecule 3; N.D., not determined.